Johnson & Johnson said Thursday that its late stage Covid-19 vaccine trial is fully enrolled. The vaccine, made by J&J subsidiary Janssen, comes in a single dose. The trial now has about 45,000 participants. J&J expects to have interim data by the end of January. If the trial goes as expected, the company said it expects to submit the trial results to the US Food and Drug Administration for an emergency use authorization in February.

Source: CNN December 18, 2020 05:03 UTC